Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Patients hospitalized with COVID-19 with high estimated blood viscosity are at higher risk of death from complications. High blood viscosity impairs flow to small vessels and increases the risk of blood clots. This measure of blood thickness can be used as a predictor of mortality.

Related Keywords

,Robert Rosenson ,Emily Henderson ,Association Of Blood Viscosity ,Icahn School Of Medicine At Mount Sinai ,Journal Of The American College Cardiology ,Mount Sinai Health System ,Blood Viscosity ,Patients Hospitalized ,American College ,Icahn School ,Mount Sinai ,Cardiometabolic Disorders ,Mount Sinai Health ,Study Is Unique ,Study Is Important ,Study Was Conducted ,Study Found ,Blood ,Covid 19 ,Albumin ,Biomarker ,Ardiology ,Ardiometabolic ,Children ,D Dimer ,Geriatrics ,Health Care ,Heparin ,Hospital ,Inflammation ,Medicine ,Ortality ,Protein ,Research ,Surgery ,